BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Prostate cancer AND WFDC2, EDDM4, HE4, WAP5, dJ461P17.6 AND Diagnosis
8 results:

  • 1. Factors influencing blood tumor marker concentrations in the absence of neoplasia.
    Trapé J; Fernández-Galán E; Auge JM; Carbonell-Prat M; Filella X; Miró-Cañís S; González-Fernández C;
    Tumour Biol; 2024; 46(s1):S35-S63. PubMed ID: 38517826
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A digital image colorimetry system based on smart devices for immediate and simultaneous determination of enzyme-linked immunosorbent assays.
    Mirhosseini S; Nasiri AF; Khatami F; Mirzaei A; Aghamir SMK; Kolahdouz M
    Sci Rep; 2024 Jan; 14(1):2587. PubMed ID: 38297148
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Development and evaluation of the MiCheck® prostate test for clinically significant prostate cancer.
    Shore ND; Polikarpov DM; Pieczonka CM; Henderson RJ; Bailen JL; Saltzstein DR; Concepcion RS; Beebe-Dimmer JL; Ruterbusch JJ; Levin RA; Wissmueller S; Le TH; Gillatt DA; Chan DW; Deng N; Siddireddy JS; Lu Y; Campbell DH; Walsh BJ
    Urol Oncol; 2023 Nov; 41(11):454.e9-454.e16. PubMed ID: 37734979
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Flexible diagnostic measures and new cut-point selection methods under multiple ordered classes.
    Feng Y; Tian L
    Pharm Stat; 2022 Jan; 21(1):220-240. PubMed ID: 34449107
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Nanotechnology in ovarian cancer: diagnosis and treatment.
    Barani M; Bilal M; Sabir F; Rahdar A; Kyzas GZ
    Life Sci; 2021 Feb; 266():118914. PubMed ID: 33340527
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.
    Cramer DW; Bast RC; Berg CD; Diamandis EP; Godwin AK; Hartge P; Lokshin AE; Lu KH; McIntosh MW; Mor G; Patriotis C; Pinsky PF; Thornquist MD; Scholler N; Skates SJ; Sluss PM; Srivastava S; Ward DC; Zhang Z; Zhu CS; Urban N
    Cancer Prev Res (Phila); 2011 Mar; 4(3):365-74. PubMed ID: 21372036
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
    Köbel M; Kalloger SE; Boyd N; McKinney S; Mehl E; Palmer C; Leung S; Bowen NJ; Ionescu DN; Rajput A; Prentice LM; Miller D; Santos J; Swenerton K; Gilks CB; Huntsman D
    PLoS Med; 2008 Dec; 5(12):e232. PubMed ID: 19053170
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Proteins with whey-acidic-protein motifs and cancer.
    Bouchard D; Morisset D; Bourbonnais Y; Tremblay GM
    Lancet Oncol; 2006 Feb; 7(2):167-74. PubMed ID: 16455481
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.